EAP treatment completed and Orphan Status achieved for MPS-I
Filed with ASX · · 3 pages · English
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Reinstatement to Official Quotation
- Paradigm completes $35m raising
- Paradigm Reports Very Encouraging Real World Data
- Paradigm receives clarity on US regulatory pathway
- Paradigm Latest Corporate Presentation
Later from Paradigm Biopharmaceuticals
- Block trade to institutional investors
- S&P DJI Announces June 2020 Quarterly Rebalance
- New financial year update
- Eap - 65% pain reduction in 10 oa patients in usa
- Quarterly Activities Report
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals